TrialThoracic cancer2020

Clinical study of apatinib combined with EGFR-TKI in the treatment of chronic progression after EGFR-TKI treatment in non-small cell lung cancer (ChiCTR1800019185).

Xin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.